Guardian Life Insurance has expanded its registered index-linked annuity (RILA), Guardian MarketPerform, to the New York market.
The product, which offers a tax-deferred retirement savings option, was initially launched nationwide in 2024.
Guardian is also introducing an additional investment customisation options for MarketPerform.
Guardian MarketPerform is designed to help individuals planning for retirement by limiting their exposure to market risk while offering the potential for investment growth.
According to the findings of Guardian’s Annual Workplace Benefits Study, 48% of New Yorkers are concerned about their financial readiness for retirement.
The product allows policyholders to track various indices.
Guardian is now enhancing MarketPerform’s investment options by adding Nasdaq-100 three and six-year terms, which will be available in all states where the product is approved.
Guardian Individual Markets head Michael Ferik said: “As a mutual insurance company, our ability to think long-term means we are well positioned to support clients and their financial well-being during periods of uncertainty. Backed by our financial strength, we are excited to expand Guardian MarketPerform’s availability to New York and add more choices to our RILA.”
In June last year, Guardian forged an alliance with Pelago, focusing on substance use management programmes including tobacco cessation.
This partnership aims to support Guardian members with workplace-sponsored dental insurance by offering a tobacco cessation programme that integrates digital tools with human coaching.
“Guardian expands MarketPerform to New York ” was originally created and published by Life Insurance International, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Add Comment